Inflammation

Pathophysiology of the Enteric Nervous System: A Basis for Understanding Functional Diseases

Volumn , Issue , 2008, Pages 61-78

  Barbara, Giovanni ^a   De Giorgio, Roberto ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Enteric nervous system; Enteroendocrine; Inflammation; Neuroplasticity; Neurotrophic molecules

Indexed keywords

EID: 84992694817     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470760307.ch6     Document Type: Chapter

References (114)

1. Sukhdeo MV, Croll NA. Gut propulsion in mice infected with Trichinella spiralis. J Parasitol 1981; 67: 906-10.
2. Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996; 111: 1683-99.
3. Sharkey KA, Mawe GM. Neuroimmune and epithelial interactions in intestinal inflammation. Curr Opin Pharmacol 2002; 2: 669-77.
4. Reinshagen M, Rohm H, Steinkamp M et al. Protective role of neurotrophins in experimental inflammation of the rat gut. Gastroenterology 2000; 119: 368-76.
5. di Mola FF, Friess H, Zhu ZW et al. Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease. Gut 2000; 46: 670-9.
6. Barbara G, Vallance BA, Collins SM. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 1997; 113: 1224-32.
7. Barbara G, De Giorgio R, Deng Y, Vallance B, Blennerhassett P, Collins SM. Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice. Gastroenterology 2001; 120: 1729-36.
8. Moreels TG, De Man JG, Bogers JJ et al. Effect of Schistosoma mansom-induced granulomatous inflammation on murine gastrointestinal motility. Am J Physiol Gastrointest Liver Physiol 2001; 280: G1030-42.
9. Heeckt PF, Haifter WM, Schraut WH, Lee KK, Bauer AJ. Small bowel transplantation and chronic rejection alter rat intestinal smooth muscle structure and function. Surgery 1993;114:449-56.
10. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001; 120:652-68.
11. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999; 45 (Suppl. 2): II43-7.
12. Isgar B, Harman M, Kaye MD, Whorwell PJ. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 1983; 24: 190-2.
13. Simren M, Axelsson J, Abrahamsson H, Svedlund J, Bjsmsson ES. Symptoms of irritable bowel syndrome in inflammatory bowel disease in remission and relationship to psychological factors [abstract]. Gastroenterology 2000; 118: A702.
14. O'Sullivan M, Clayton N, Breslin NP et al. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000; 12: 449-57.
15. Chadwick VS, Chen W, Shu D et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002; 122: 1778-83.
16. Barbara G, Stangheilini V, De Giorgio R et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693-702.
17. Dunlop SP, Jenkins D, Neal KR et al. Randomized, double-blind, placebo-controlled trial of prednisolone in postinfectious irritable bowel syndrome. Aliment Pharmacol Ther 2003; 18: 77-84.
18. Thoreux K, Owen RL, Schmucker DL. Intestinal lymphocyte number, migration and antibody secretion in young and old rats. Immunology 2000; 101: 161-7.
19. Bradesi S, Eutamene H, Theodorou V, Fioramonti J, Bueno L. Effect of ovarian hormones on intestinal mast cell reactivity to substance P. Life Sei 2001; 68: 1047-56.
20. Salzmann JL, Peltier-Koch F, Bloch F, Petite JP, Camilleri JP. Morphometric study of colonic biopsies: a new method of estimating inflammatory diseases. Lab Invest 1989; 60: 847-51.
21. Weston AP, Biddle WL, Bhatia PS, Miner PB Jr. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig DisSci 1993; 38: 1590-5.
22. Gwee KA, Leong YL, Graham C et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999; 44: 400-6.
23. Spiller RC, Jenkins D, Thornley JP et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804-11.
24. Gwee KA, Collins SM, Read NW et al. Increased rectal mucosal expression of interleukin Ibeta in recently acquired post-infectious irritable bowel syndrome. Gut 2003; 52: 523-6.
25. Galeazzi F, Haapala EM, van Rooijen N, Vallance BA, Collins SM. Inflammation-induced impairment of enteric nerve function in nematode-infected mice is macrophage dependent. Am J Physiol Gastrointest Liver Physiol 2000; 278: G259-65.
26. Coelho AM, Fioramonti J, Bueno L. Systemic lipopolysaccharide influences rectal sensitivity in rats: role of mast cells, cytokines, and vagus nerve. Am J Physiol Gastrointest Liver Physiol 2000; 279: G781-90.
27. Weinberg JB. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol Med 1998; 4: 557-91.
28. Shah V, Lyford G, Gores G, Farruggia G. Nitric oxide in gastrointestinal health and disease. Gastroenterology 2004; 126: 903-13.
29. Coutinho SV, Gebhart GF. A role for spinal nitric oxide in mediating visceral hyperalgesia in the rat. Gastroenterology 1999; 116: 1399-408.
30. O'Sullivan M, Clayton N, Moloney G et al. Increased iNOS expression in irritable bowel syndrome (IBS) patients with stress related symptoms [abstract]. Gastroenterology 2003; 124: M1642.
31. Barbara G, De Giorgio R, Stangheilini V, Cremon C, Corinaldesi R. A role for inflammation in irritable bowel syndrome? Gut 2002; 51 (Suppl. 1): 41-4.
32. Stead RH, Dixon MF, Bramwell NH, Riddell RH, Bienenstock J. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 1989; 97: 575-85.
33. Stead RH, Tomioka M, Quinonez G, Simon GT, Feiten SY, Bienenstock J. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sei USA 1987; 84: 2975-9.
34. Reed DE, Barajas-Lopez C, Cottrell G et al. Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea-pig submucosal neurons. J Physiol 2003; 547: 531-42.
35. Gao C, Liu S, Hu HZ et al. Serine proteases excite myenteric neurons through protease-activated receptors in guinea pig small intestine. Gastroenterology 2002; 123: 1554-64.
36. Nozdrachev AD, Akoev GN, Filippova LV et al. Changes in afferent impulse activity of small intestine mesenteric nerves in response to antigen challenge. Neuroscience 1999; 94: 1339-42.
37. Bueno L, Fioramonti J, Delvaux M, Frexinos J. Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology 1997; 112: 1714-43.
38. Castex N, Fioramonti J, Fargeas MJ, More J, Bueno L. Role of 5-HT3 receptors and afferent fibers in the effects of mast cell degranulation on colonic motility in rats. Gastroenterology 1994; 107: 976-84.
39. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. Proteinase-activated receptors. Pharmacol Rev 2001; 53: 245-82.
40. Coelho AM, Vergnolle N, Guiard B, Fioramonti J, Bueno L. Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats. Gastroenterology 2002; 122: 1035-47.
41. Tamura K, Wood JD. Effects of prolonged exposure to histamine on guinea pig intestinal neurons. Dig Dis Sei 1992; 37: 1084-8.
42. Fu LW, Pan HL, Longhurst JC. Endogenous histamine stimulates chemically sensitive abdominal visceral afferents through HI receptors. Am J Physiol 1997; 273: H2726-37.
43. Liu S, Hu HZ, Gao N, Gao C et al. Neuroimmune interactions in guinea pig stomach and small intestine. Am J Physiol Gastrointest Liver Physiol 2003; 284: G154-64.
44. Schuurs AH, Verheul HA. Effects of gender and sex steroids on the immune response. J Steroid Biochem 1990; 35: 157-72.
45. Chang L, Heitkemper MM. Gender differences in irritable bowel syndrome. Gastroenterology 2002; 123: 1686-701.
46. Wood JD. Neuropathophysiology of irritable bowel syndrome. J Clin Gastroenterol 2002; 35: SI 1-22.
47. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology2003; 124: 1662-71.
48. Locke GR III, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ III. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc 2000; 75: 90712.
49. Morris-Yates A, Talley NJ, Boyce PM, Nandurkar S, Andrews G. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol 1998; 93: 1311-7.
50. Levy RL, Jones KR, Whitehead WE, Feld SI, Talley N J, Corey LA. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology 2001; 121: 799-804.
51. Gonsalkorale WM, Perrey C, Pravica V, Whorwell PJ, Hutchinson IV. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut 2003; 52: 91-3.
52. Maluenda C, Phillips AD, Briddon A, Walker-Smith JA. Quantitative analysis of small intestinal mucosa in cow's milk-sensitive enteropathy. J Pediatr Gastroenterol Nutr 1984; 3: 349-56.
53. Wershil BK, Furuta GT, Wang ZS, Galli SJ. Mast cell-dependent neutrophil and mononuclear cell recruitment in immunoglobulin E-induced gastric reactions in mice. Gastroenterology 1996; 110: 1482-90.
54. Smout A, Azpiroz F, Coremans G et al. Potential pitfalls in the differential diagnosis of irritable bowel syndrome. Digestion 2000; 61: 247-56.
55. Eutamene H, Theodorou V, Fioramonti J, Bueno L. Acute stress modulates the histamine content of mast cells in the gastrointestinal tract through interleukin-1 and corticotropin-releasing factor release in rats. J Physiol 2003; 553: 959-66.
56. Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 1998; 42: 845-9.
57. Sciarretta G, Fagioli G, Furno A et al. 75Se HCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit. Gut 1987; 28:970-5.
58. King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998; 352: 1187-9.
59. Krishnamurthy S, Schuffler MD. Pathology of neuromuscular disorders of the small intestine and colon. Gastroenterology 1987; 93:610-39.
60. De Giorgio R, Stanghellini V, Barbara G et al. Primary enteric neuropathies underlying gastrointestinal motor dysfunction. Scand J Gastroenterol 2000; 35: 114-22.
61. Krishnamurthy S, Schuffler MD, Belie L, Schweid AL An inflammatory axonopathy of the myenteric plexus producing a rapidly progressive intestinal pseudoobstruction. Gastroenterology 1986; 90: 754-8.
62. Wood JD. Neuropathy in the brain-in-the-gut. Eur J Gastroenterol Hepatol 2000; 12: 597-600.
63. Smith W, Gregson N, Foggensteiner L, Neale G, Milla PJ. Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement. Gastroenterology 1997; 112: 1366-71.
64. Goldblum JR, Rice TW, Richter JE. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 1996; 111: 648-54.
65. De Giorgio R, Barbara G, Stanghellini V et al. Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult. Eur J Gastroenterol Hepatol 2000; 12: 613-16.
66. Schuffler MD, Baird HW, Fleming CR et al. Intestinal pseudo-obstruction as the presenting manifestation of small-cell carcinoma of the lung. A paraneoplastic neuropathy of the gastrointestinal tract. Ann Intern Med 1983; 98: 129-34.
67. De Giorgio R, Barbara G, Stanghellini V et al. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases. Am J Gastroenterol 2002; 97: 2454-9.
68. Chinn JS, Schuffler MD. Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction. Gastroenterology 1988; 95: 1279-86.
69. Lee HR, Lennon VA, Camilleri M, Prather CM. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol 2001; 96: 373-9.
70. Schobinger-Clement S, Gerber HA, Stallmach T. Autoaggressive inflammation of the myenteric plexus resulting in intestinal pseudoobstruction. Am J Surg Pathol 1999; 23:602-6.
71. McDonald GB, Schuffler MD, Kadin ME, Tytgat GN. Intestinal pseudoobstruction caused by diffuse lymphoid infiltration of the small intestine. Gastroenterology 1985; 89: 882-9.
72. Schappi MG, Smith W, Milla PJ, Lindley KJ. Eosinophilic myenteric ganglionitis is associated with functional intestinal obstruction. Gut 2003; 52: 752-5.
73. De Giorgio R, Guerrini S, Barbara G et al. Inflammatory neuropathies of the enteric nervous system. Gastroenterology 2004; 126: 1873-83.
74. De Giorgio R, Camilleri M. Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil 2004. (In press.).
75. Tornblom H, Lindberg G, Nyberg B, Veress B. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002; 123: 1972-9.
76. Clark SB, Rice TW, Tubbs RR, Richter JE, Goldblum JR. The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am J Surg Pathol 2000; 24: 1153-8.
77. De Giorgio R, Barbara G, Pulsatelli L et al. Chemokine expression and lymphocyte subsets in patients with idiopathic myenteric ganglionitis [abstract]. Gastroenterology 2000; 118:A630.
78. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392: 565-8.
79. Bogers J, Moreels T, De Man J et al. Schistosoma mansoniinfection causing diffuse enteric inflammation and damage of the enteric nervous system in the mouse small intestine. Neurogastroenterol Motil 2000; 12: 431-40.
80. Lennon VA. Calcium channel and related paraneoplastic disease autoantibodies. In: Peter, JB, Shoenfeld Y, eds. Textbook of Autoantibodies. Amsterdam: Elsevier Science, 1996: 139-47.
81. Vincent A, Dalton P, Clover L, Palace J, Lang B. Antibodies to neuronal targets in neurological and psychiatric diseases. Ann N Y Acad Sei 2003; 992: 48-55.
82. Dropcho EJ. Remote neurologic manifestations of cancer. Neurol Clin 2002; 20: 85-122.
83. Benyahia B, Liblau R, Merle-Beral H, Tourani JM, Dalmau J, Delattre JY. Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. Ann Neurol 1999; 45: 162-7.
84. Wakamatsu Y, Weston JA. Sequential expression and role of Hu RNA-binding proteins during neurogenesis. Development 1997; 124: 3449-60.
85. Waterman SA. Autonomic dysfunction in Lambert-Eaton myasthenic syndrome. Clin Auton Res 2001; 11: 145-54.
86. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 2000; 343: 847-55.
87. Okano HJ, Park WY, Corradi JP, Darnell RB. The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival. Genes Dev 1999; 13: 2087-97.
88. Moses PL, Ellis LM, Anees MR, Ho W, Rothstein RI, Meddings JB, Sharkey KA, Mawe GM. Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut 2003; 52: 629-36.
89. Volta U, De Giorgio R, Petrolini N et al. Clinical findings and anti-neuronal antibodies in coeliac disease with neurological disorders. Scand J Gastroenterol 2002; 37: 1276-81.
90. Goldblatt F, Gordon TP, Waterman SA. Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology 2002; 123: 1144-50.
91. Caras SD, McCallum HR, Brashear HR, Smith TK. The effect of human antineuronal antibodies on the ascending excitatory reflex and peristalsis in isolated guinea pig ileum: 'Is the paraneoplastic syndrome a motor neuron disorder?' [abstract]. Gastroenterology 1996; 110: A643.
92. De Giorgio R, Bovara M, Barbara G et al. Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility. Gastroenterology 2003; 125: 70-9.
93. Eaker EY, Kuldau JG, Verne GN, Ross SO, Sallustio JE. Myenteric neuronal antibodies in scleroderma: passive transfer evokes alterations in intestinal myoelectric activity in a rat model. J Lab Clin Med 1999; 133: 551-6.
94. Lennon VA, Ermilov LG, Szurszewski JH, Vernino S. Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J Clin invest 2003; 111:907-13.
95. Vassallo M, Camilleri M, Caron BL, Low PA. Gastrointestinal motor dysfunction in acquired selective cholinergic dysautonomia associated with infectious mononucleosis. Gastroenterology 1991; 100: 252-8.
96. Chang AE, Young NA, Reddick RL et al. Small bowel obstruction as a complication of disseminated varicella-zoster infection. Surgery 1978; 83: 371-4.
97. Robertson CS, Martin BA, Atkinson M. Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut 1993; 34: 299-302.
98. Chen JJ, Gershon AA, Li ZS, Lungu O, Gershon MD. Latent and lytic infection of isolated guinea pig enteric ganglia by varicella zoster virus. J Med Virol 2003; 70 (Suppl. 1): S71-8.
99. Debinski HS, Kamm MA, Talbot IC, Khan G, Kangro HO, Jeffries DJ. DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction. Gut 1997; 41: 100-6.
100. Sonsino E, Mouy R, Foucaud P, Cezard JP, Aigrain Y, Bocquet L, Navarro J. Intestinal pseudoobstruction related to cytomegalovirus infection of myenteric plexus. N Engl J Med 1984; 311: 196-7.
101. Ruhl A, Trotter J, Stremmel W. Isolation of enteric glia and establishment of transformed enteroglial cell lines from the myenteric plexus of adult rat. Neurogastroenterol Motil 2001; 13: 95-106.
102. Ruhl A, Franzke S, Collins SM, Stremmel W. Interleukin-6 expression and regulation in rat enteric glial cells. Am J Physiol Gastrointest Liver Physiol 2001; 280: Gl 163-71.
103. Bush TG, Puvanachandra N, Horner CH et al. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 1999; 23: 297-308.
104. Bush TG, Savidge TC, Freeman TC et al. Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell 1998; 93: 189-201.
105. Pande R, Leis AA. Myasthenia gravis, thymoma, intestinal pseudo-obstruction, and neuronal nicotinic acetylcholine receptor antibody. Muscle Nerve 1999; 22: 1600-2.
106. Meneghelli UG. Chagas' disease: a model of denervation in the study of digestive tract motility. Braz J Med Biol Res 1985; 18: 255-64.
107. Chamond N, Coatnoan N, Minoprio P. Immunotherapy of Trypanosoma cruziinfections. Curr Drug Targets Immune Endocr Metab Disord 2002; 2: 247-54.
108. Williams-Blangero S, Vande Berg JL, Blangero J, Correa-Oliveira R. Genetic epidemiology of Trypanosoma cruzi infection and Chagas' disease. Front Biosci 2003; 8: e337-45.
109. Van Voorhis WC, Schlekewy L, Trong HL. Molecular mimicry by Trypanosoma cruzi: the Fl-160 epitope that mimics mammalian nerve can be mapped to a 12-amino acid peptide. Proc Natl Acad Sci USA 1991; 88: 5993-7.
110. Horoupian DS, Kim Y. Encephalomyeloneuropathy with ganglionitis of the myenteric plexuses in the absence of cancer. Ann Neurol 1982; 11:628-32.
111. Gershon MD, Kirchgessner AL, Wade PR. Functional anatomy of the enteric nervous system. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. New York: Raven Press, 1994: 381-422.
112. Furness JB, Costa M. The Enteric Nervous System. Edinburgh: Churchill-Livingstone, 1987.
113. Furness JB, Bornstein JC. The enteric nervous system and its extrinsic connections. In: Yamada T, ed. Textbook of Gastroenterology. New York: Lippincott, 1991: 2-24.
114. Wood JD. Neural and humoral regulation of gastrointestinal motility. In: Schuster MM, Crowell MD, Koch KL, eds. Gastrointestinal Motility in Health and Disease. Hamilton: B.C. Decker, 2002: 19-42.